• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Vesper Healthcare Acquisition Corp.

    5/5/21 4:08:44 PM ET
    $VSPR
    Business Services
    Finance
    Get the next $VSPR alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-39565
    Issuer: Beauty Health Co
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 1819 West Avenue Bay 2
    Miami Beach FLORIDA 33139
    Telephone number: (786) 216-7037
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Vesper Healthcare Acquisition Corp. Unit
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2021-05-05 By Tara Petta Director
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $VSPR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSPR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VSPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Linden and DW Healthcare Partners Complete HydraFacial's Public Offering via SPAC Merger

    CHICAGO and PARK CITY, Utah, May 5, 2021 /PRNewswire/ -- Linden Capital Partners ("Linden") and DW Healthcare Partners IV, LP ("DW Healthcare Partners"), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of Edge Systems, LLC ("HydraFacial"), a category-creating beauty health company, with Vesper Healthcare Acquisition Corp. (NASDAQ:VSPR) ("Vesper" or "Vesper Healthcare"). Vesper is a special purpose acquisition company ("SPAC") led by former Allergan CEO Brent Saunders. As a result of the transaction, the combined company, now known as The Beauty Health Company ("BeautyHealth" or the "Company"), is expected to trade on the Na

    5/5/21 7:30:00 AM ET
    $VSPR
    Business Services
    Finance

    HydraFacial Announces Record First Quarter Fiscal 2021 Preliminary Net Sales

    First Quarter 2021 Preliminary Financial Highlights: Q1 net sales of $47 million compared to $33 million in Q1 2020 and $35 million in Q1 2019 Q1 net sales in the Americas region of $31 million, or 66% of total net sales, compared to $24 million in Q1 2020 and $27 million in Q1 2019 Q1 net sales in the EMEA and APAC regions of $16 million, or 34% of total sales, compared to $9 million in Q1 2020 and $8 million in Q1 2019 The HydraFacial® Company ("HydraFacial," or the "Company"), an experiential category-creating beauty health company, today announced preliminary net sales for the quarter ended March 31, 2021. The Company has not yet completed the quarter-end review and expects to r

    4/21/21 6:45:00 AM ET
    $VSPR
    Business Services
    Finance

    HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales

    MIAMI BEACH, Fla. & LONG BEACH, Calif.--(BUSINESS WIRE)--The HydraFacial® Company (“HydraFacial,” or the “Company”), a category-creating beauty health company, today announced preliminary net sales for the fiscal year ended December 31, 2020. HydraFacial currently expects net sales for fiscal year 2020 to approximate $119 million. The Company’s previous expectation for net sales, provided on December 9, 2020, was approximately $115 million. The Company has not yet completed the year-end audit and expects to report full results for fiscal year 2020 at a future date. The previously announced business combination with Vesper Healthcare (NASDAQ: VSPR) remains on track to be completed

    2/22/21 6:45:00 AM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Woo Liyuan

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 8:00:17 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by LCP Edge Holdco LLC

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 4:34:28 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by SAUNDERS BRENT L

    4 - Beauty Health Co (0001818093) (Issuer)

    5/18/21 9:22:28 PM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    SEC Filings

    View All

    $VSPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SEC Form 4 filed by Vesper Healthcare Acquisition Corp.

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 8:00:45 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by Vesper Healthcare Acquisition Corp.

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 7:59:07 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 8-K filed by Vesper Healthcare Acquisition Corp.

    8-K - Beauty Health Co (0001818093) (Filer)

    5/20/21 4:07:22 PM ET
    $VSPR
    Business Services
    Finance

    DA Davidson initiated coverage on Vesper Healthcare Acquisition Corp. with a new price target

    DA Davidson initiated coverage of Vesper Healthcare Acquisition Corp. with a rating of Buy and set a new price target of $15.50

    4/13/21 6:59:11 AM ET
    $VSPR
    Business Services
    Finance

    The Benchmark Company initiated coverage on Vesper Healthcare Acquisition Corp. with a new price target

    The Benchmark Company initiated coverage of Vesper Healthcare Acquisition Corp. with a rating of Buy and set a new price target of $16.00

    3/18/21 7:41:55 AM ET
    $VSPR
    Business Services
    Finance

    Benchmark initiated coverage on Vesper Healthcare with a new price target

    Benchmark initiated coverage of Vesper Healthcare with a rating of Buy and set a new price target of $16.00

    3/18/21 6:57:43 AM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Vesper Healthcare Acquisition Corp. (Amendment)

    SC 13D/A - Beauty Health Co (0001818093) (Subject)

    5/21/21 4:30:37 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form SC 13D filed by Vesper Healthcare Acquisition Corp.

    SC 13D - Beauty Health Co (0001818093) (Subject)

    5/14/21 4:23:32 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form SC 13G filed

    SC 13G - Vesper Healthcare Acquisition Corp. (0001818093) (Subject)

    2/16/21 3:58:03 PM ET
    $VSPR
    Business Services
    Finance